Leukemia, Monocytic, Chronic
|
0.300 |
Biomarker
|
disease |
CTD_human |
Germline duplication of ATG2B and GSKIP predisposes to familial myeloid malignancies.
|
26280900 |
2015 |
Myeloid Leukemia
|
0.300 |
Biomarker
|
disease |
CTD_human |
Germline duplication of ATG2B and GSKIP predisposes to familial myeloid malignancies.
|
26280900 |
2015 |
Myeloproliferative disease
|
0.300 |
Biomarker
|
group |
CTD_human |
Germline duplication of ATG2B and GSKIP predisposes to familial myeloid malignancies.
|
26280900 |
2015 |
Crohn Disease
|
0.010 |
Biomarker
|
disease |
BEFREE |
miR-143 may induce bowel inflammation by regulating ATG2B and autophagy, suggesting that miR-143 might play a critical role in the development of CD.
|
29562274 |
2018 |
Exfoliation Syndrome
|
0.010 |
Biomarker
|
disease |
BEFREE |
Our results suggest that these three genes that are critical components of the autophagy pathway (ATG16L, ATG2B, ATG5) are not significant risk factors among Spanish patients with either XFS or XFG.
|
27960588 |
2018 |
Oral Cavity Carcinoma
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
We found an association between the variant in ATG10 rs1864183 and a higher susceptibility to develop laryngeal cancer, ATG2B rs3759601 and pharyngeal cancer and ATG16L1 rs2241880 and oral carcinoma.
|
28761177 |
2017 |
Malignant neoplasm of pharynx
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
We found an association between the variant in ATG10 rs1864183 and a higher susceptibility to develop laryngeal cancer, ATG2B rs3759601 and pharyngeal cancer and ATG16L1 rs2241880 and oral carcinoma.
|
28761177 |
2017 |
Lip and Oral Cavity Carcinoma
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
We found an association between the variant in ATG10 rs1864183 and a higher susceptibility to develop laryngeal cancer, ATG2B rs3759601 and pharyngeal cancer and ATG16L1 rs2241880 and oral carcinoma.
|
28761177 |
2017 |
Pharyngeal Carcinoma
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
We found an association between the variant in ATG10 rs1864183 and a higher susceptibility to develop laryngeal cancer, ATG2B rs3759601 and pharyngeal cancer and ATG16L1 rs2241880 and oral carcinoma.
|
28761177 |
2017 |
Squamous cell carcinoma of the head and neck
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
To investigate the importance of this pathway in HNSCC susceptibility, a risk factor matched case-control association study was performed with four candidate polymorphisms in autophagy genes (ATG2B, ATG5, ATG10, ATG16L1).
|
28761177 |
2017 |
Epithelial ovarian cancer
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
Common variant rs8170 and rare variants in ATG2B may be associated with EOC overall survival, although further study is needed.
|
26747452 |
2016 |
Tumor Cell Invasion
|
0.010 |
AlteredExpression
|
phenotype |
BEFREE |
In the two gastric epithelial cell lines, mimic mir-30d was found to repress the autophagy process, whereas mir-30d inhibitor increased autophagy response to H. pylori invasion. mir-30d mimic decreased the luciferase activity of wild type reporter plasmids carrying the 3' untranslated region (UTR) of all five tested genes (ATG2B, ATG5, ATG12, BECN1, and BNIP3L), whereas it had no effect on the mutant reporter plasmids.
|
27099441 |
2016 |
Sporadic Breast Carcinoma
|
0.010 |
PosttranslationalModification
|
disease |
BEFREE |
Aberrant methylation of ATG2B, ATG4D, ATG9A and ATG9B CpG island promoter is associated with decreased mRNA expression in sporadic breast carcinoma.
|
27265029 |
2016 |
Carcinoma, Ovarian Epithelial
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
Common variant rs8170 and rare variants in ATG2B may be associated with EOC overall survival, although further study is needed.
|
26747452 |
2016 |
Malignant Neoplasms
|
0.010 |
GeneticVariation
|
group |
BEFREE |
Germline duplication of ATG2B and GSKIP predisposes to familial myeloid malignancies.
|
26280900 |
2015 |
Non-Small Cell Lung Carcinoma
|
0.010 |
Biomarker
|
disease |
BEFREE |
These results suggested that ATG2B may be a new potential therapeutic target for NSCLC.
|
25322940 |
2015 |
Malignant neoplasm of urinary bladder
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
Finally, we demonstrate that rs3759601 in ATG2B correlates with progression and recurrence of bladder cancer after BCG intravesical instillation therapy.
|
25356988 |
2014 |
Bladder Neoplasm
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
Finally, we demonstrate that rs3759601 in ATG2B correlates with progression and recurrence of bladder cancer after BCG intravesical instillation therapy.
|
25356988 |
2014 |
Carcinoma of bladder
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
Finally, we demonstrate that rs3759601 in ATG2B correlates with progression and recurrence of bladder cancer after BCG intravesical instillation therapy.
|
25356988 |
2014 |